Pearson Lab
@lab_pearson
University of Chicago head and neck cancer lab doing research at the interface of computational methods, tumor biology, and clinical relevance. PI: Alex Pearson
You might like
🤖 Join the Artificial Intelligence in Cancer Research Summer School 2025 hosted by @IstTumori- A pioneering event where cutting-edge technology meets life-saving medical innovation. More info ➡️ aicancer2025.org
At #ASCO25, Frederick Howard, MD, presents a poster showing high efficiency of AI models that accurately predicts treatment outcomes in breast cancer patients, offering a faster, more scalable alternative to traditional genomic testing. @fredhow @lab_pearson @UChicagoHemOnc
From ambient dictation tools to FDA-approved diagnostics, #AI is transforming oncology! At #ASCO25, Alexander Pearson, MD, PhD presents how AI is reshaping clinical cancer care—from research to bedside. @UChicagoMed @UChicagoHemOnc @lab_pearson
🧐Our DEPEND trial is out! Neoadjuvant nivo/chemo followed by response-stratified CRT in HPV-negative stage IVa/b HNSCC. @UCCancerCenter @UChicagoHemOnc @ajuloorimd @lab_pearson @HNCancerDoc @EIzumchenko @eevokes jamanetwork.com/journals/jamao…
Jazzed to see our work describing *potential LLM use trends in @ASCO abstracts* as one of the @JCO_ASCO family top articles of 2024. Check out all the top articles here: ascopubs.org/2024-top-artic…. @fredhow @LGM_Biostats @JCOCCI_ASCO @UCCancerCenter @UChicagoBSD
The #callforabstracts for our annual AI for Oncology conference in @IstTumori (May 8-9, 2025) is open until Feb 3rd - aiforoncology.it/call-for-abstr… We really look forward to your submissions! And the top 3 will have the chance to present in front of a stellar lineup - don't miss it!
Thanks so much @BasuLab1 @LovaSunMD @PennHeadandNeck! What a great opportunity to brainstorm science together.
It was a privilege to host @lab_pearson together with @LovaSunMD as part of our Head and Neck Cancer Center of Excellence lecture series and learn about progress toward AI-based discrimination of actionable states for cancer therapy.
Generative artificial intelligence for drug discovery: how the first AI-discovered and AI-designed drug progressed to phase 2 clinical testing #behindthepaper communities.springernature.com/posts/generati…
Honored to present our translational research at @TheVFoundation symposium. Thank you for the invtation and your support! @UCCancerCenter @UChicagoMed @UChicagoHemOnc @UofC @UChicagoCCB
It’s personal for our researchers. @AkashPatnaik7 from @UChicagoMed shares how he lost his uncle to prostate cancer and how that gave him the drive to research this type of cancer.
Incredibly excited to share our open-source Common Longitudinal ICU data Format (CLIF)! We hope CLIF will substantially improve the efficiency of critical illness research and evaluation of important ICU quality measures Appreciate any and all feedback!
🚨 Just released! 🚨 Excited to share our new preprint on the Common Longitudinal ICU Data Format (CLIF)! This open-source format standardizes ICU data for federated research, advancing AI and critical care research. Check it out: (medrxiv.org/content/10.110…) #ICU #DataScience #AI
🚀 Big news! Slideflow 3.0 is here! 🎉 We've revamped our licensing (now Apache-2.0) to make Slideflow more open & accessible. We've added 3 foundation models (Virchow, UNI, GigaPath), upgraded MIL, & much more. Check it out: github.com/slideflow/slid… #AI #Pathology #OpenSource
github.com
GitHub - slideflow/slideflow: Powerful, open-source AI tools for digital pathology.
Powerful, open-source AI tools for digital pathology. - slideflow/slideflow
Fantastic news!
Thank you @woldloren! I am honored to receive this award from @ConquerCancerFd. I have been blessed with incredible mentorship on this project from the Applebaum lab @UChiPritzker @d_golden @lab_pearson & @spshubeck. Excited to present @ASCO! conquer.org/news/conquer-c… @FutureDocs
Check out our multi-center phase 2 IIT currently accruing for upfront SBRT added to Durvalumab-based chemoimmunotherapy for the first line treatment of extensive stage SCLC - the DARES trial. @ChristineBestv1 @Docace911 clinical-lung-cancer.com/article/S1525-…
Looking forward to this terrific session!
🔜#ASCOBT24 Day1⃣ 🔥Artificial Intelligence in the Cancer Clinic ✅Overview: Chair &🎙️@lab_pearson ✅Pathology: 🎙️Joe Poh Sheng Yeong ✅Large Language Models:🎙️Danielle Sara Bitterman ✅Precision oncology: 🎙️Caroline Chung @OncoAlert @ASCO @JSMO_official conferences.asco.org/breakthrough/
U.S. News & World Report's Best Hospitals list ranked University of Chicago Medical Center's Cancer and ENT programs highest in Illinois. Additionally, UCMC is one of only 25 hospitals nationwide to have at least 10 ranked specialties. uchicagomedicine.org/forefront/news…
Ecstatic to join 1st cohort of #CZBiohubCHI Investigators, with @EsserKahnLab + Peter Maurer. Our squad will use quantum-enabled IDs⚛️to eval individual immune cells in real-time to describe disease like malignant transformation🦀. @czbiohub @UChicagoMed @UChicago @UCCancerCenter
🎉Congratulations to the 2024 #CZBiohubCHI Investigators! The cohort of 48 of Chicago’s most creative and accomplished scientists and engineers will use multidisciplinary approaches to understand inflammation and the dysregulation of immune cells.
Priviliged to have spent 4 days with friends and colleagues from all over the 🌎in the beautiful historic setting of AKSS Spetses for the first “Workshop on AI in Oncology: applications & challenges”. We interacted and learned from AI experts, delved into the exciting new world…
Ugh. Program termination applies to: TrilynX (NCT04459715) XRAY VISION (NCT05386550)
BAD NEWS! -- Xevinapant +cis in HN Phase 3 negative at interim -- cis ineligible study closing down -- not great news for #hncsm #radonc @NRGonc (h/t @yaoyu_md) @CJTsaiMDPhD @KaramLab @imrtlee @HenningWillers emdgroup.com/en/news/xevina…
@fredhow and colleagues published a great study in @JCOCCI_ASCO during #ASCO24 reporting increased use of AI tools in scientific writing, warning authors to be responsible for accurate representation of content. @lab_pearson @UChicagoHemOnc @UCCancerCenter ow.ly/hUTB50Sim17
United States Trends
- 1. Marshawn Kneeland 7,918 posts
- 2. Nancy Pelosi 13.9K posts
- 3. #MichaelMovie 18.6K posts
- 4. ESPN Bet 1,828 posts
- 5. Good Thursday 33.3K posts
- 6. Gremlins 3 1,745 posts
- 7. Madam Speaker N/A
- 8. #thursdayvibes 2,640 posts
- 9. Jaafar 5,586 posts
- 10. Happy Friday Eve N/A
- 11. Joe Dante N/A
- 12. Penn 8,756 posts
- 13. Mega Chimecho 2,827 posts
- 14. #BrightStar_THE8Day 20.8K posts
- 15. Baxcalibur 2,436 posts
- 16. #ThursdayThoughts 1,775 posts
- 17. #별보다빛나는_명호_생일축하해 20.8K posts
- 18. Chris Columbus 1,699 posts
- 19. Korrina 2,545 posts
- 20. Barstool 1,452 posts
You might like
-
AHNS
@AHNSinfo -
Anant Madabhushi
@anantm -
Jakob Nikolas Kather
@jnkath -
Robert Ferris, MD, PhD
@RobertFerrisMD -
Robert Haddad
@DrHaddadRobert -
Walter Stadler
@WalterStadler5 -
Kunle Odunsi, MD
@KunleOdunsiMD -
University of Chicago Hem/Onc Fellows
@UCHemOncFellows -
Ari Rosenberg
@AriRosenbergMD -
University of Chicago Hematology/Oncology
@UChicagoHemOnc -
Nabil Saba, MD
@DrNabilSaba -
Devraj Basu, MD, PhD, FACS
@BasuLab1 -
Ravi Uppaluri, MDPhD
@DrUppaluri -
Fred Howard
@fredhow -
Sean Pitroda, M.D.
@SeanPitroda
Something went wrong.
Something went wrong.